Team:Bielefeld-Germany/Biosafety/Safety-Form

From 2013.igem.org

(Difference between revisions)
Line 13: Line 13:
==<span style = "color:#f88101; padding-left:22px">'''Safety Form'''</span> ==
==<span style = "color:#f88101; padding-left:22px">'''Safety Form'''</span> ==
-
<!-- El manu -->
+
===Basic Safety Questions for iGEM 2013===
<br>
<br>
 +
*1.Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:
 +
<br>
 +
[[File:IGEM Bielefeld 2013 Biosafety Safety form tab organisms.png|600px|thumb|center|Table of the chassis organisms we use for our project.]]
 +
 +
<br>
 +
*2. Highest Risk Group Listed:
 +
**The highest risk group is one.
 +
<br>
 +
 +
*3. List and describe all new or modified coding regions you will be using in your project.
 +
<br>
 +
[[File:IGEM Bielefeld 2013 Biosafety tab codingregions zusammen.png|600px|thumb|center|Table of the coding regions we use in our project.]]
 +
<br>
 +
 +
*4. Do the biological materials used in your lab work pose any of the following risks? Please describe.
 +
**a. Risks to the safety and health of team members or others working in the lab?
 +
*** see 1)<br>
 +
**b. Risks to the safety and health of the general public, if released by design or by accident?
 +
*** No. All our strains are based on E. coli K12.<br>
 +
**c. Risks to the environment, if released by design or by accident?
 +
*** No. All our strains are based on E. coli K12.<br>
 +
**d. Risks to security through malicious misuse by individuals, groups, or countries?
 +
***No. All our strains are based on E. coli K12. All the genes that are introduced are not suited for malicious misuse.
 +
<br>
 +
 +
*5. If your project moved from a small-scale lab study to become widely used as commercial/industrial product, what new risks might arise?  Also, what risks might arise if the knowledge you generate or the methods you develop became widely available? <br>
 +
** If our system become widely used as a commercial/industrial product there doesn't arise new risks. It is only for producing electricity so this scenario has just positive consequences.
 +
<br>
 +
 +
*6. Does your project include any design features to address safety risks?<br>
 +
**Yes it includes a kill switch and an especially safe auxotrophic chassis.
 +
 +
*7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.
 +
**All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.<br>
 +
 +
*8. Under what biosafety provisions will / do you work?
 +
**a. Please provide a link to your institution biosafety guidelines.
 +
*** Our university has an own health, work and environment protection management system, certified with the British standard [http://uni-bielefeld.agu-hochschulen.de/index.php?id=714 „Occupational Health and Safety Assessment Series“ (BS OHSAS 18001)]:
 +
 

Revision as of 08:30, 1 October 2013




Safety Form

Basic Safety Questions for iGEM 2013


  • 1.Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:


Table of the chassis organisms we use for our project.


  • 2. Highest Risk Group Listed:
    • The highest risk group is one.


  • 3. List and describe all new or modified coding regions you will be using in your project.


Table of the coding regions we use in our project.


  • 4. Do the biological materials used in your lab work pose any of the following risks? Please describe.
    • a. Risks to the safety and health of team members or others working in the lab?
      • see 1)
    • b. Risks to the safety and health of the general public, if released by design or by accident?
      • No. All our strains are based on E. coli K12.
    • c. Risks to the environment, if released by design or by accident?
      • No. All our strains are based on E. coli K12.
    • d. Risks to security through malicious misuse by individuals, groups, or countries?
      • No. All our strains are based on E. coli K12. All the genes that are introduced are not suited for malicious misuse.


  • 5. If your project moved from a small-scale lab study to become widely used as commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available?
    • If our system become widely used as a commercial/industrial product there doesn't arise new risks. It is only for producing electricity so this scenario has just positive consequences.


  • 6. Does your project include any design features to address safety risks?
    • Yes it includes a kill switch and an especially safe auxotrophic chassis.
  • 7. What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.
    • All the members of our team received instructions by Mr. Dr. Jörn Kalinowski according to German lab safety regulations including working with biological genetically engineered materials.
  • 8. Under what biosafety provisions will / do you work?
    • a. Please provide a link to your institution biosafety guidelines.
      • Our university has an own health, work and environment protection management system, certified with the British standard [http://uni-bielefeld.agu-hochschulen.de/index.php?id=714 „Occupational Health and Safety Assessment Series“ (BS OHSAS 18001)]:

 

Retrieved from "http://2013.igem.org/Team:Bielefeld-Germany/Biosafety/Safety-Form"